Clinical outcome after endovascular treatment for isolated common femoral and popliteal artery disease View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2013-01-30

AUTHORS

Yoshimitsu Soga, Yusuke Tomoi, Kei Sato, Osamu Iida, Hiroyoshi Yokoi

ABSTRACT

The safety and patency of endovascular treatment (EVT) in isolated common femoral artery (CFA) and popliteal artery (PA) remain poorly understood. We investigated the efficacy after EVT for isolated CFA and PA disease. This study was performed as a multicenter retrospective registry of a prospectively maintained database. Between January 2001 and December 2010, consecutive 183 patients (214 lesions; CFA 111, PA 103) who received endovascular procedure for de novo isolated CFA and PA disease were enrolled. The main endpoints of this study were primary and secondary patency after EVT. Procedure success was 95.8 %. The 1- and 5-year primary patencies for CFA (PA) lesions after EVT were 73.5 % (75.5 %) and 46.9 % (56.2 %), respectively. There was no significant difference of primary patency rate between CFA and PA (46.9 vs. 56.2 % at 5-year, p = 0.83). However, secondary patency significantly differed between CFA and PA (97.6 vs. 86.2 % at 5-year, p = 0.009). Stent placement was not effective for the reduction of restenosis in both CFA and PA lesion. On multivariate analysis to define the predictors of primary patency for the CFA, renal failure, coronary artery disease, calcified lesion and residual stenosis after EVT were independent predictors. Also, the predictors of primary patency for the PA were BMI, reference vessel diameter, anemia and residual stenosis after EVT. Short-term patency after EVT for isolated CFA and PA lesion seems to be feasible. However, long-term patency was not promising. Furthermore, stent placement does not improve the primary patency. More... »

PAGES

250-257

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12928-013-0164-1

DOI

http://dx.doi.org/10.1007/s12928-013-0164-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1035385457

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/23361951


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Arterial Occlusive Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aspirin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Endovascular Procedures", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Femoral Artery", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Platelet Aggregation Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Popliteal Artery", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vascular Patency", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Kokura Memorial Hospital, 1-1 Asano, Kokurakita-ku, 802-0001, Kitakyushu, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415432.5", 
          "name": [
            "Department of Cardiology, Kokura Memorial Hospital, 1-1 Asano, Kokurakita-ku, 802-0001, Kitakyushu, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Soga", 
        "givenName": "Yoshimitsu", 
        "id": "sg:person.01276714415.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276714415.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Kokura Memorial Hospital, 1-1 Asano, Kokurakita-ku, 802-0001, Kitakyushu, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415432.5", 
          "name": [
            "Department of Cardiology, Kokura Memorial Hospital, 1-1 Asano, Kokurakita-ku, 802-0001, Kitakyushu, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tomoi", 
        "givenName": "Yusuke", 
        "id": "sg:person.01104331243.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104331243.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Japan", 
          "id": "http://www.grid.ac/institutes/grid.414976.9", 
          "name": [
            "Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sato", 
        "givenName": "Kei", 
        "id": "sg:person.01222237135.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222237135.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Japan", 
          "id": "http://www.grid.ac/institutes/grid.414976.9", 
          "name": [
            "Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Iida", 
        "givenName": "Osamu", 
        "id": "sg:person.01016335235.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016335235.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Kokura Memorial Hospital, 1-1 Asano, Kokurakita-ku, 802-0001, Kitakyushu, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415432.5", 
          "name": [
            "Department of Cardiology, Kokura Memorial Hospital, 1-1 Asano, Kokurakita-ku, 802-0001, Kitakyushu, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yokoi", 
        "givenName": "Hiroyoshi", 
        "id": "sg:person.01052603744.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01052603744.16"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2013-01-30", 
    "datePublishedReg": "2013-01-30", 
    "description": "The safety and patency of endovascular treatment (EVT) in isolated common femoral artery (CFA) and popliteal artery (PA) remain poorly understood. We investigated the efficacy after EVT for isolated CFA and PA disease. This study was performed as a multicenter retrospective registry of a prospectively maintained database. Between January 2001 and December 2010, consecutive 183 patients (214 lesions; CFA 111, PA 103) who received endovascular procedure for de novo isolated CFA and PA disease were enrolled. The main endpoints of this study were primary and secondary patency after EVT. Procedure success was 95.8\u00a0%. The 1- and 5-year primary patencies for CFA (PA) lesions after EVT were 73.5\u00a0% (75.5\u00a0%) and 46.9\u00a0% (56.2\u00a0%), respectively. There was no significant difference of primary patency rate between CFA and PA (46.9 vs. 56.2\u00a0% at 5-year, p\u00a0=\u00a00.83). However, secondary patency significantly differed between CFA and PA (97.6 vs. 86.2\u00a0% at 5-year, p\u00a0=\u00a00.009). Stent placement was not effective for the reduction of restenosis in both CFA and PA lesion. On multivariate analysis to define the predictors of primary patency for the CFA, renal failure, coronary artery disease, calcified lesion and residual stenosis after EVT were independent predictors. Also, the predictors of primary patency for the PA were BMI, reference vessel diameter, anemia and residual stenosis after EVT. Short-term patency after EVT for isolated CFA and PA lesion seems to be feasible. However, long-term patency was not promising. Furthermore, stent placement does not improve the primary patency.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s12928-013-0164-1", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1042779", 
        "issn": [
          "1868-4300", 
          "1868-4297"
        ], 
        "name": "Cardiovascular Intervention and Therapeutics", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "28"
      }
    ], 
    "keywords": [
      "common femoral artery", 
      "endovascular treatment", 
      "popliteal artery", 
      "primary patency", 
      "secondary patency", 
      "residual stenosis", 
      "artery disease", 
      "stent placement", 
      "PA lesions", 
      "multicenter retrospective registry", 
      "popliteal artery disease", 
      "primary patency rate", 
      "reference vessel diameter", 
      "coronary artery disease", 
      "short-term patency", 
      "long-term patency", 
      "reduction of restenosis", 
      "retrospective registry", 
      "CFA lesions", 
      "renal failure", 
      "independent predictors", 
      "clinical outcomes", 
      "main endpoint", 
      "patency rates", 
      "femoral artery", 
      "procedure success", 
      "endovascular procedures", 
      "patency", 
      "multivariate analysis", 
      "lesions", 
      "disease", 
      "vessel diameter", 
      "stenosis", 
      "significant differences", 
      "artery", 
      "predictors", 
      "treatment", 
      "de novo", 
      "BMI", 
      "patients", 
      "anemia", 
      "registry", 
      "restenosis", 
      "placement", 
      "endpoint", 
      "efficacy", 
      "outcomes", 
      "study", 
      "safety", 
      "failure", 
      "novo", 
      "differences", 
      "database", 
      "rate", 
      "procedure", 
      "reduction", 
      "success", 
      "analysis", 
      "diameter"
    ], 
    "name": "Clinical outcome after endovascular treatment for isolated common femoral and popliteal artery disease", 
    "pagination": "250-257", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1035385457"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12928-013-0164-1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "23361951"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12928-013-0164-1", 
      "https://app.dimensions.ai/details/publication/pub.1035385457"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-11-24T20:56", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_605.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s12928-013-0164-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12928-013-0164-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12928-013-0164-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12928-013-0164-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12928-013-0164-1'


 

This table displays all metadata directly associated to this object as RDF triples.

227 TRIPLES      20 PREDICATES      103 URIs      95 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12928-013-0164-1 schema:about N0c332526c9a5414ab3ec83934f9fd62f
2 N1f12b09a0b73410485a35726a6e4b7b8
3 N2bff61a5d3e6405c8c386fb71ec64a99
4 N2c18a1c3aeaa4f1781512e747de6fd3d
5 N302302e45b174c2f9144c7ee26986cb6
6 N30b8a5fda8a74a909b0f712a072f18a8
7 N46be8c30d5f646d5878499175c2972c9
8 N47b321a827a049298842f9bdce24fe87
9 N6ee2eec51cfc47008754fe657493ae71
10 N75355697c7804b2293cb5a9d04b037c1
11 N764bdfa62cf24a82869a9fceac4ee8be
12 N767f9b5ed35f44539c9356dd82072a34
13 N7b46b388135e4fa7a44f09081dcdac03
14 Na62eefa9652b4a8785a95bde8bafdb71
15 Nb57921313052482583939cf5cfa1e5ad
16 Nbe8e3596f6e04af0a5daeb79cf3cfa92
17 Nd802601dd9b3450da95047ed9e254c66
18 Ne1e84d796ba5474bae541a5d4c84b7f7
19 Nee4335b8952b4eb99fa148099c6fbe09
20 anzsrc-for:11
21 anzsrc-for:1102
22 schema:author N9873d852fd704b91a62e99384539ad98
23 schema:datePublished 2013-01-30
24 schema:datePublishedReg 2013-01-30
25 schema:description The safety and patency of endovascular treatment (EVT) in isolated common femoral artery (CFA) and popliteal artery (PA) remain poorly understood. We investigated the efficacy after EVT for isolated CFA and PA disease. This study was performed as a multicenter retrospective registry of a prospectively maintained database. Between January 2001 and December 2010, consecutive 183 patients (214 lesions; CFA 111, PA 103) who received endovascular procedure for de novo isolated CFA and PA disease were enrolled. The main endpoints of this study were primary and secondary patency after EVT. Procedure success was 95.8 %. The 1- and 5-year primary patencies for CFA (PA) lesions after EVT were 73.5 % (75.5 %) and 46.9 % (56.2 %), respectively. There was no significant difference of primary patency rate between CFA and PA (46.9 vs. 56.2 % at 5-year, p = 0.83). However, secondary patency significantly differed between CFA and PA (97.6 vs. 86.2 % at 5-year, p = 0.009). Stent placement was not effective for the reduction of restenosis in both CFA and PA lesion. On multivariate analysis to define the predictors of primary patency for the CFA, renal failure, coronary artery disease, calcified lesion and residual stenosis after EVT were independent predictors. Also, the predictors of primary patency for the PA were BMI, reference vessel diameter, anemia and residual stenosis after EVT. Short-term patency after EVT for isolated CFA and PA lesion seems to be feasible. However, long-term patency was not promising. Furthermore, stent placement does not improve the primary patency.
26 schema:genre article
27 schema:isAccessibleForFree false
28 schema:isPartOf N1e76970d35594cc8937babdfef4bca6a
29 Nd2dbbad984db414f86c8fb0ebd6806fb
30 sg:journal.1042779
31 schema:keywords BMI
32 CFA lesions
33 PA lesions
34 analysis
35 anemia
36 artery
37 artery disease
38 clinical outcomes
39 common femoral artery
40 coronary artery disease
41 database
42 de novo
43 diameter
44 differences
45 disease
46 efficacy
47 endovascular procedures
48 endovascular treatment
49 endpoint
50 failure
51 femoral artery
52 independent predictors
53 lesions
54 long-term patency
55 main endpoint
56 multicenter retrospective registry
57 multivariate analysis
58 novo
59 outcomes
60 patency
61 patency rates
62 patients
63 placement
64 popliteal artery
65 popliteal artery disease
66 predictors
67 primary patency
68 primary patency rate
69 procedure
70 procedure success
71 rate
72 reduction
73 reduction of restenosis
74 reference vessel diameter
75 registry
76 renal failure
77 residual stenosis
78 restenosis
79 retrospective registry
80 safety
81 secondary patency
82 short-term patency
83 significant differences
84 stenosis
85 stent placement
86 study
87 success
88 treatment
89 vessel diameter
90 schema:name Clinical outcome after endovascular treatment for isolated common femoral and popliteal artery disease
91 schema:pagination 250-257
92 schema:productId N87470c561f854384bceef27cf6db692f
93 Nc9bcc6578ab145f29de5d22ce08854fc
94 Nf7e73e5532f642d3a51a44fc4da15856
95 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035385457
96 https://doi.org/10.1007/s12928-013-0164-1
97 schema:sdDatePublished 2022-11-24T20:56
98 schema:sdLicense https://scigraph.springernature.com/explorer/license/
99 schema:sdPublisher N39b1e8fdb5454a508c6a1db2371cfea7
100 schema:url https://doi.org/10.1007/s12928-013-0164-1
101 sgo:license sg:explorer/license/
102 sgo:sdDataset articles
103 rdf:type schema:ScholarlyArticle
104 N0c332526c9a5414ab3ec83934f9fd62f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Humans
106 rdf:type schema:DefinedTerm
107 N1e76970d35594cc8937babdfef4bca6a schema:volumeNumber 28
108 rdf:type schema:PublicationVolume
109 N1f12b09a0b73410485a35726a6e4b7b8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Female
111 rdf:type schema:DefinedTerm
112 N2bff61a5d3e6405c8c386fb71ec64a99 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Follow-Up Studies
114 rdf:type schema:DefinedTerm
115 N2c18a1c3aeaa4f1781512e747de6fd3d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Aspirin
117 rdf:type schema:DefinedTerm
118 N302302e45b174c2f9144c7ee26986cb6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Middle Aged
120 rdf:type schema:DefinedTerm
121 N30b8a5fda8a74a909b0f712a072f18a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Arterial Occlusive Diseases
123 rdf:type schema:DefinedTerm
124 N39b1e8fdb5454a508c6a1db2371cfea7 schema:name Springer Nature - SN SciGraph project
125 rdf:type schema:Organization
126 N4665730a4ba14cf8971d9c2b7daf6b84 rdf:first sg:person.01016335235.39
127 rdf:rest Na86a1cf8d8854ccfafd0ed429501c64d
128 N46be8c30d5f646d5878499175c2972c9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Adult
130 rdf:type schema:DefinedTerm
131 N47b321a827a049298842f9bdce24fe87 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Vascular Patency
133 rdf:type schema:DefinedTerm
134 N557ad6ba058c45c88e614815ba8f604e rdf:first sg:person.01222237135.86
135 rdf:rest N4665730a4ba14cf8971d9c2b7daf6b84
136 N64492c0ce36d4cde9666f08e1d6c5ec7 rdf:first sg:person.01104331243.48
137 rdf:rest N557ad6ba058c45c88e614815ba8f604e
138 N6ee2eec51cfc47008754fe657493ae71 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Aged
140 rdf:type schema:DefinedTerm
141 N75355697c7804b2293cb5a9d04b037c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Femoral Artery
143 rdf:type schema:DefinedTerm
144 N764bdfa62cf24a82869a9fceac4ee8be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Endovascular Procedures
146 rdf:type schema:DefinedTerm
147 N767f9b5ed35f44539c9356dd82072a34 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Platelet Aggregation Inhibitors
149 rdf:type schema:DefinedTerm
150 N7b46b388135e4fa7a44f09081dcdac03 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Male
152 rdf:type schema:DefinedTerm
153 N87470c561f854384bceef27cf6db692f schema:name dimensions_id
154 schema:value pub.1035385457
155 rdf:type schema:PropertyValue
156 N9873d852fd704b91a62e99384539ad98 rdf:first sg:person.01276714415.24
157 rdf:rest N64492c0ce36d4cde9666f08e1d6c5ec7
158 Na62eefa9652b4a8785a95bde8bafdb71 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Aged, 80 and over
160 rdf:type schema:DefinedTerm
161 Na86a1cf8d8854ccfafd0ed429501c64d rdf:first sg:person.01052603744.16
162 rdf:rest rdf:nil
163 Nb57921313052482583939cf5cfa1e5ad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Treatment Outcome
165 rdf:type schema:DefinedTerm
166 Nbe8e3596f6e04af0a5daeb79cf3cfa92 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Stents
168 rdf:type schema:DefinedTerm
169 Nc9bcc6578ab145f29de5d22ce08854fc schema:name doi
170 schema:value 10.1007/s12928-013-0164-1
171 rdf:type schema:PropertyValue
172 Nd2dbbad984db414f86c8fb0ebd6806fb schema:issueNumber 3
173 rdf:type schema:PublicationIssue
174 Nd802601dd9b3450da95047ed9e254c66 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Popliteal Artery
176 rdf:type schema:DefinedTerm
177 Ne1e84d796ba5474bae541a5d4c84b7f7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Prospective Studies
179 rdf:type schema:DefinedTerm
180 Nee4335b8952b4eb99fa148099c6fbe09 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Dose-Response Relationship, Drug
182 rdf:type schema:DefinedTerm
183 Nf7e73e5532f642d3a51a44fc4da15856 schema:name pubmed_id
184 schema:value 23361951
185 rdf:type schema:PropertyValue
186 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
187 schema:name Medical and Health Sciences
188 rdf:type schema:DefinedTerm
189 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
190 schema:name Cardiorespiratory Medicine and Haematology
191 rdf:type schema:DefinedTerm
192 sg:journal.1042779 schema:issn 1868-4297
193 1868-4300
194 schema:name Cardiovascular Intervention and Therapeutics
195 schema:publisher Springer Nature
196 rdf:type schema:Periodical
197 sg:person.01016335235.39 schema:affiliation grid-institutes:grid.414976.9
198 schema:familyName Iida
199 schema:givenName Osamu
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016335235.39
201 rdf:type schema:Person
202 sg:person.01052603744.16 schema:affiliation grid-institutes:grid.415432.5
203 schema:familyName Yokoi
204 schema:givenName Hiroyoshi
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01052603744.16
206 rdf:type schema:Person
207 sg:person.01104331243.48 schema:affiliation grid-institutes:grid.415432.5
208 schema:familyName Tomoi
209 schema:givenName Yusuke
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104331243.48
211 rdf:type schema:Person
212 sg:person.01222237135.86 schema:affiliation grid-institutes:grid.414976.9
213 schema:familyName Sato
214 schema:givenName Kei
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222237135.86
216 rdf:type schema:Person
217 sg:person.01276714415.24 schema:affiliation grid-institutes:grid.415432.5
218 schema:familyName Soga
219 schema:givenName Yoshimitsu
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276714415.24
221 rdf:type schema:Person
222 grid-institutes:grid.414976.9 schema:alternateName Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Japan
223 schema:name Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Japan
224 rdf:type schema:Organization
225 grid-institutes:grid.415432.5 schema:alternateName Department of Cardiology, Kokura Memorial Hospital, 1-1 Asano, Kokurakita-ku, 802-0001, Kitakyushu, Japan
226 schema:name Department of Cardiology, Kokura Memorial Hospital, 1-1 Asano, Kokurakita-ku, 802-0001, Kitakyushu, Japan
227 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...